Additionally, the study integrates virtual screening and molecular dynamics (MD) simulations to identify small-molecule compounds targeting YBX1, thereby providing both mechanistic insights and therapeutic candidates for IPF. The gene discussed is YBX1; the disease is idiopathic pulmonary fibrosis.